Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
67.50    0.00 (0.00%)
Bid:
65.00
Ask:
70.00
Spread: 5.00 (7.692%)
Market Cap: £9.29m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

New Contract Win

5 Jul 2011 07:00

RNS Number : 7416J
Croma Group PLC
05 July 2011
 



Croma Group PLC ("Croma" or "the Group")

 

New Contract Win

 

Croma, the AIM listed total security services provider is delighted to announce a significant contract win awarded to Photobase, Croma's access security and installation systems subsidiary. Photobase has been contracted by CSS Total Security Ltd ("CSS") for the development of security software.

 

The contract is worth £450,000, Photobase's largest contract win to date, and marks a further step in the cooperation between Croma and CSS. Croma will announce a pre-close trading update for the financial year ended 30 June 2011 later this month.

 

Sebastian Morley CEO of Croma Group Plc comments:

 

"This is an important and deeply significant contract win not only financially but also operationally. It marks further cooperation between the two groups in bringing a total security solution to our respective and joint clients."

 

For further information please contact:

 

Croma Group PLC:

Sebastian Morley, CEO

Tel: 07768 006 909

Brewin Dolphin (NOMAD):

Sandy Fraser, Managing Director - Corporate Finance

Tel: 0845 213 2072

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUSOVRAOABRAR
Date   Source Headline
3rd Jul 20237:00 amRNSCompletion of the Disposal & Total Voting Rights
30th Jun 20239:32 amRNSResult of General Meeting
6th Jun 20237:00 amRNSProposed Disposal of Vigilant for £6.5 million
28th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSDirectorate Change
14th Mar 20237:00 amRNSHalf-year Report
20th Jan 20237:00 amRNSDirectorate Change
20th Dec 20227:00 amRNSAcquisition of Safecell Security Group
6th Dec 20223:51 pmRNSResult of AGM
6th Dec 20227:00 amRNSAGM Statement, Potential Divestment, Board Changes
11th Nov 20227:00 amRNSFinal Results
27th Oct 20227:00 amRNSPublication of 2022 Final Results
15th Sep 20227:00 amRNSContract Wins & Trading Update
6th Jul 20227:00 amRNSAcquisition
31st Mar 20225:08 pmRNSDirector/PDMR Shareholding
29th Mar 20222:50 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSHalf-year Report
24th Jan 20227:00 amRNSStrategic Partnership
26th Nov 202112:03 pmRNSGrant of Options, PDMR dealing
24th Nov 20211:36 pmRNSResult of AGM
18th Nov 20217:00 amRNSAcquisition
8th Nov 202112:28 pmRNSHolding(s) in Company
28th Oct 20212:38 pmRNSHolding(s) in Company
21st Oct 20217:00 amRNSFinal Results
6th Oct 202110:54 amRNSHolding(s) in Company
4th Oct 20217:00 amRNSTrading Statement and Strategic Partnership
2nd Jul 20217:44 amRNSHolding(s) in Company
28th Jun 20217:00 amRNSTrading Statement
24th Mar 20217:00 amRNSDirector/PDMR Shareholding
12th Mar 202110:07 amRNSHolding(s) in Company
1st Mar 20217:00 amRNSHalf-year Report
18th Jan 20217:00 amRNSHolding(s) in Company
25th Nov 20201:52 pmRNSResult of AGM
21st Oct 20207:00 amRNSFinal Results
13th Aug 202011:00 amRNSDividend Reinstated and Contract Win
2nd Jul 20207:00 amRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSContract Renewal and Uplift
8th Jun 20207:00 amRNSTrading Update
4th Jun 20204:40 pmRNSSecond Price Monitoring Extn
4th Jun 20204:35 pmRNSPrice Monitoring Extension
19th Mar 20203:01 pmRNSCancellation of Dividend
2nd Mar 20207:00 amRNSHalf-year Report
4th Feb 20208:12 amRNSHolding(s) in Company
24th Jan 202012:00 pmRNSHolding(s) in Company
27th Nov 20191:32 pmRNSResult of AGM
21st Oct 20197:00 amRNSFinal Results
29th Mar 20196:00 pmRNSHolding(s) in Company
18th Mar 201912:58 pmRNSDirector/PDMR Shareholding
26th Feb 20194:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.